Oncoinvent Receives FDA Fast Track Designation for Radspherin® as Treatment for Peritoneal Carcinomatosis from Ovarian Cancer

By /

Oncoinvent Receives FDA Fast Track Designation for Radspherin ® as Treatment for Peritoneal Carcinomatosis from Ovarian Cancer.

Scroll to Top